Stephen B. Hamilton
General Electric
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen B. Hamilton.
Toxicological Sciences | 1998
Brian A. Mayes; E.E. McConnell; B.H. Neal; M.J. Brunner; Stephen B. Hamilton; Timothy Sullivan; A. Peters; Michael J. Ryan; John D. Toft; A. W. Singer; John F. Brown; R.G. Menton; J.A. Moore
A comprehensive chronic toxicity and carcinogenicity study was conducted on a series of Aroclors (1016, 1242, 1254, and 1260). Each Aroclor was assessed at multiple dietary concentrations, ranging from 25 to 200 ppm, for 24 months in male and female Sprague-Dawley rats. Liver toxicity was indicated by elevated serum enzyme activity (AST, ALT, and GGT), elevated serum cholesterol concentration, decreases in hematologic parameters (RBC, Hb, and Hct), hepatocellular hypertrophy, an increased incidence of altered hepatocellular foci, and an increased incidence of hepatocellular neoplasms (primarily adenomas). Liver toxicity was distinctly more severe in females than in males. The incidence of hepatocellular neoplasms was highly sex-dependent (females >> males), differed between Aroclor mixtures and, for females, increased with dose and followed the general incidence pattern of Aroclor 1254 > Aroclor 1260 approximately Aroclor 1242 > Aroclor 1016. A significant response (p < 0.05) in males was seen only for the high dose of Aroclor 1260. A small increase in the incidence of thyroid gland follicular cell adenomas was noted in males for Aroclors 1242, 1254, and 1260, with the incidence being uniform across dose groups and Aroclor mixtures. For females, increased survival relative to controls was observed for all Aroclor treatment groups. A significantly decreased trend in the incidence of mammary gland neoplasms compared to control was also noted for females receiving Aroclors 1242, 1254, and 1260.
Chemosphere | 1988
John F. Brown; James Claude Carnahan; Steven B. Dorn; James T. Groves; Woodfin V. Ligon; Ralph J. May; Robert E. Wagner; Stephen B. Hamilton
Abstract The levels of three pharmacologically active PCDF congeners, namely the 2,3,7,8,-tetra-, 2,3,4,7,8-penta-, and 1,2,3,7,8,9-hexachlorodibenzofurans, were measured by a precise two-dimensional gas chromatographic mass spectrometric procedure in PCB dielectric fluids taken from both used and unused capacitors and transformers, as well as in Aroclor standards. It was found that the electrical uses did not cause increases in bioactive PCDF levels.
1983 EIC 6th Electrical/Electronical Insulation Conference | 1983
Stephen B. Hamilton
When Polychlorinated biphenyls (PCBs) were first introduced on the market as dielectric fluids, they were heralded as a major safety breakthrough. Fire safety codes demanded that PCB transformers and capacitors be used in major buildings. Some insurance companies would not write insurance on buildings that did not have PCB transformers.
Toxicological Sciences | 2005
Jay B. Silkworth; Aruna Koganti; Kati Illouz; Antonio Possolo; Ming Zhao; Stephen B. Hamilton
Chemosphere | 1989
John F. Brown; Richard W. Lawton; M.R. Ross; J. Feingold; Robert E. Wagner; Stephen B. Hamilton
Toxicological Sciences | 2007
John F. Brown; Brian A. Mayes; Jay B. Silkworth; Stephen B. Hamilton
Archive | 1968
Stephen B. Hamilton; Robert J Kelly; Robert C. Wells
Archive | 1974
Melvin D. Beers; Abe Berger; Stephen B. Hamilton; Terry G. Selin
Archive | 1974
Stephen B. Hamilton; Warren Roy Lampe
Regulatory Toxicology and Pharmacology | 2002
Brian A. Mayes; George L. Brown; Frank J. Mondello; Kevin W. Holtzclaw; Stephen B. Hamilton; Arthur A. Ramsey